Please note - companies listed have provided sponsorship supporting the conference, with no input or control over the agenda, content creation, or speaker selection, except for their sponsored sessions.

Based in Parma, Italy, Chiesi Farmaceutici is an international research-focused biopharmaceuticals group with over 85 years’ experience in the pharmaceutical sector operating in 30 countries, employing around 6,000 people. The Group’s research and development centre in Parma works alongside six other important R&D hubs in France, the US, Canada, China, the UK, and Sweden. Chiesi develops and markets innovative therapeutic solutions in respiratory health, rare diseases, and specialty care. The company’s mission is to improve people’s quality of life and act responsibly towards both the community and the environment. As a certified B Corp since 2019, Chiesi is part of a global community of businesses that meet high standards of social and environmental impact. The company aims at becoming net-zero by 2035. Chiesi Limited is headquartered in Manchester and employs over 400 people. Further information: www.chiesi.uk.com

At Kenvue, we realize the extraordinary power of everyday care.

Through our iconic brands – including Aveeno®, Johnson’s®, Listerine®, Neutrogena® and Nicorette® – we put this power into the hands of approximately 1.2 billion people globally, in their daily rituals and the moments that matter most. We are 22,000 dynamic and diverse team members, passionate about insights, innovation and making an impact.

We are united by an unwavering courage to see and solve everyday care needs by delivering science-backed, care-forward experiences that are endorsed by healthcare professionals. With expertise and empathy, we believe in meaningful possibilities for healthier people. And we’re focused on this pursuit.

As the world’s largest pure-play consumer health company by revenue, we bring a new view of everyday care to the world.

Learn more at www.kenvue.com

Organon has a mission to deliver impactful medicines and solutions for a healthier every day. We build upon our strong foundation of more than 60 medicines and other products across a range of areas including reproductive health, heart disease, dermatology, allergy and asthma. We bring these important therapies around the world, with an international footprint that serves people in more than 140 markets. We believe the diversity of our business provides a sustainable engine of growth so we can continue to invest in and advance new medicines and treatments for women that are so urgently needed. We are here for her health.

.

Abbott is a global healthcare leader that helps people live more fully at all stages of life. Our portfolio of life-changing technologies spans the spectrum of healthcare, with leading businesses and products in diagnostics, medical devices, nutritionals and branded generic medicines. Our 114,000 colleagues serve people in more than 160 countries.

At Abbott, we believe people with diabetes should enjoy active lives, so we’re focused on making breakthrough technology accessible and approachable for all. Our groundbreaking sensing technology is revolutionising how people monitor glucose and providing healthcare professionals with more data to make better informed treatment decisions.

https://pro.freestyle.abbott/uk-en/home.htmlKind

Aspire Pharma is a UK-based life sciences business, devoted to delivering true value to patients, healthcare professionals and the NHS.

Aspire’s mission is to ‘make a difference in the lives of patients through the development and supply of innovative products and medicines throughout the world’.

Aspire supplies a range of pharmaceuticals and medical devices, both prescription and over the counter (OTC). All products are carefully selected to deliver value and differentiation to both patients and prescribers. The focus is on extending Aspire's portfolio of innovative products in the UK and globally, for the long-term benefit of patients, partners and customers.

www.aspirepharma.co.uk.

10103472456 v 1.0 August 2024

Aqua is a leading provider in primary care recruitment. We supply various clinical and non-clinical staff, both salaried and locum to various settings across the United Kingdom. Our specialist consultants provide a bespoke service to both our candidates and clients to insure the best possible care for patients.

Since 1963 Dermal has been at the forefront of innovative topical formulations, developing highly effective, cosmetically acceptable, and clinically proven therapies for the management of skin conditions. We understand that it is the performance of the formulation that makes the difference and can improve patient adherence.

Hear our news on the stand:

· Our latest addition, Doublebase Once, is proven to provide 24 hours’ hydration from 1 application. Come and see the new study data.

· We surveyed Healthcare Professionals on their experience using Adex Gel – and the results are in!

· Newly updated Dermol Dossier is now available to access.  

www.dermal.co.uk.

We are Diabetes UK. Our vision is a world where diabetes can do no harm. It’s why we campaign for better care, give support in times of need and fund ground-breaking research into new treatments and a cure.

Come and visit the Diabetes UK stand to find out more about our CPD e-learning courses, and register for free today. We have modules on Diabetes Technology, Diabetes and Emotional Wellbeing, Type 2 Remission and more. Build the confidence, skills, and knowledge to support people living with and at risk of diabetes.

Gedeon Richter have a presence in over 100 countries worldwide and have been working to change lives for the better since 1901. We are one of the few companies in the world to offer a comprehensive portfolio for women; our R&D team continue to innovate and extend our gynaecological, fertility and osteoporosis portfolio, aiming to address women’s healthcare needs in these areas. Our ambition is to help women achieve theirs.

Glenmark is a research‐led, global pharmaceutical company, with presence across branded, generics, and OTC segments; our focus therapy areas are Respiratory, Dermatology and Oncology. We are focused on developing bioequivalent as well as innovative medicines that make a difference to the NHS and fulfil the unmet needs of patients.

January 2025, PP-UK-Bun-0089

Orion Pharma (UK) Ltd. is a wholly owned subsidiary of Orion Corporation, pharmaceutical company based in Finland. Our principal role is to represent Orion's pharmaceutical products in the UK across a range of therapy areas including Respiratory, Women’s Health and Neurological Disorders.

In the spirit of the values which are common to all units and employees of the Group, we endeavour to provide innovative medicinal treatments and best quality service to patients, healthcare professionals and the community in the UK, the region we operationally cover.

We are continuously developing new drugs and treatment methods. The core therapy areas of our pharmaceutical R&D are oncology and pain.​ We collaborate closely with healthcare professionals and leading global research institutions and pharmaceutical companies.

www.orionpharma.co.uk

July 2023/CORP-233(3)

TriOn Pharma is a dynamic UK-based Nutraceutical, Pharmaceutical, and Medical Device company, committed to pioneering innovative, high-quality, and cost-effective products to enhance health and well-being. As an ethical pharmaceutical firm, we collaborate with the NHS to optimize drug budgets without compromising quality.